We are live on ! Find out more
UTHR icon

United Therapeutics
UTHR

400 hedge funds and large institutions have $6.44B invested in United Therapeutics in 2017 Q4 according to their latest regulatory filings, with 62 funds opening new positions, 135 increasing their positions, 139 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

94% more first-time investments, than exits

New positions opened: 62 | Existing positions closed: 32

50% more funds holding in top 10

Funds holding in top 10: 4 → 6 (+2)

26% more capital invested

Capital invested by funds: $5.13B → $6.44B (+$1.31B)

7% more funds holding

Funds holding: 373 → 400 (+27)

0.49% more ownership

Funds ownership: 100.54% → 101.03% (+0.49%)

3% less repeat investments, than reductions

Existing positions increased: 135 | Existing positions reduced: 139

11% less call options, than puts

Call options by funds: $20.4M | Put options by funds: $23M

Holders
400
Holders Change
+27
Holders Change %
+7.24%
% of All Funds
9.07%
Holding in Top 10
6
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+50%
% of All Funds
0.14%
New
62
Increased
135
Reduced
139
Closed
32
Calls
$20.4M
Puts
$23M
Net Calls
-$2.55M
Net Calls Change
-$45.6M

Top Buyers

1
Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB)
Sweden
+$47.1M
2
WCM
Wedge Capital Management
North Carolina
+$39.8M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
+$24.4M
4
Renaissance Technologies
Renaissance Technologies
New York
+$24.1M
5
Fidelity International
Fidelity International
Bermuda
+$20.8M

Top Sellers

1
Morgan Stanley
Morgan Stanley
New York
-$43.6M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$31.4M
3
AQR Capital Management
AQR Capital Management
Connecticut
-$31.4M
4
Schroder Investment Management Group
Schroder Investment Management Group
United Kingdom
-$24.2M
5
State Street
State Street
Massachusetts
-$21.7M
Name Holding Trade Value Shares
Change 		Change in
Stake
FA
251
FDx Advisors
Illinois
$643K -$46.1K -363 -8%
PPCM
252
Pillar Pacific Capital Management
California
$618K +$5.08K +40 +1%
CS
253
Candriam SCA
Luxembourg
$613K +$244K +1,919 +86%
IUHSA
254
Itau Unibanco Holding S.A.
Brazil
$607K -$112K -878 -18%
MCM
255
Mork Capital Management
California
$607K – – –
Tudor Investment Corp
256
Tudor Investment Corp
Connecticut
$604K -$469K -3,692 -47%
PAM
257
Panagora Asset Management
Massachusetts
$601K +$5.85K +46 +1%
MM
258
Midas Management
New York
$595K – – –
QI
259
QS Investors
New York
$595K – – –
EVM
260
Eaton Vance Management
Massachusetts
$580K -$30.3K -238 -6%
MYLI
261
Meiji Yasuda Life Insurance
Japan
$558K +$243K +1,910 +103%
WS
262
Wedbush Securities
California
$549K – – –
FWM
263
Frontier Wealth Management
Missouri
$540K – – –
LIA
264
LS Investment Advisors
Michigan
$536K -$97K -763 -17%
PM
265
Parametrica Management
Hong Kong
$534K +$459K +3,611 New
O
266
OppenheimerFunds
New York
$526K +$8.26K +65 +2%
DVM
267
Dreman Value Management
Florida
$513K – – –
ONB
268
Old National Bancorp
Indiana
$507K – – –
IFS
269
Ifrah Financial Services
Arkansas
$501K -$121K -949 -22%
Brown Advisory
270
Brown Advisory
Maryland
$481K +$31.8K +250 +8%
CB
271
Cadence Bank
Mississippi
$478K +$411K +3,230 New
SCM
272
Shelton Capital Management
Colorado
$474K – – –
RI
273
Ridgewood Investments
New Jersey
$473K – – –
TCM
274
Teza Capital Management
Illinois
$473K +$407K +3,200 New
MCM
275
Matarin Capital Management
New York
$458K – – –
9 10
11
12 13

UTHR Hedge Fund Activity: Q4 2017 in Review

400 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in United Therapeutics (UTHR) for Q4 2017, worth a combined $6.44B — up 26% from $5.13B a quarter earlier.

Buyers outnumbered sellers: 62 funds opened new UTHR positions and 32 closed out — a net gain of 30 holders — while 135 added to existing stakes and 139 trimmed.

The largest buyer was Skandinaviska Enskilda Banken (SEB), adding an estimated $47.1M. The largest seller was Morgan Stanley, cutting an estimated $43.6M.

  • 400 institutional investors held United Therapeutics (UTHR) as of Q4 2017, up from 373 in Q3 2017.
  • Funds reported $6.44B of United Therapeutics stock for Q4 2017, up 26% quarter-over-quarter.
  • 62 funds opened new United Therapeutics positions in Q4 2017 and 32 closed out, a net change of +30 holders.
  • The largest United Therapeutics buyer in Q4 2017 was Skandinaviska Enskilda Banken (SEB), an estimated $47.1M added.
  • The largest United Therapeutics seller in Q4 2017 was Morgan Stanley, an estimated $43.6M sold.

Based on aggregated 13F filings for Q4 2017.